Navigation Links
Elbit Imaging Ltd. Announces Second Quarter Results for 2008
Date:8/31/2008

TEL AVIV, Israel, Aug. 31 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (Nasdaq: EMITF) ("EI" or the "Company") today announced its results for the second quarter of 2008.

Profit for the second quarter of 2008 amounted to NIS 56.0 million (approximately US$ 16.7 million) of which profit of NIS 15.8 million (approximately US$ 4.7 million) is attributable to the equity holders of the Company and NIS 40.3 million (approximately US$ 12.0 million) is attributable to minority interest, compared with profit of NIS 83.6 million in the corresponding period of 2007 of which NIS 57.7 million is attributable to the equity holders of the Company and NIS 25.8 million is attributable to minority interest.

Profit for the second quarter of 2008 excluding stock-base compensation expenses (Non GAAP measure) amounted to NIS 66.8 million (approximately US$ 19.9 million) compared with NIS 100.9 million in the corresponding period of 2007.

Our audited consolidated financial statements for the second quarter of 2008 presentation are available through our website at: http://www.elbitimaging.com under: "Investor Relations - Company Presentations (8/2008)."

Mr. Shimon Yitzhaki, President, commented: "Even in these restless times in the markets, specifically the real-estate markets, Elbit Imaging is pleased to report a profitable quarter. Elbit Imaging continues to implement a policy under which it does not revaluate its real estate assets. As such, Elbit Imaging's profits are recognized on a cash flow basis and from the Group's core business activities. In this quarter we completed and delivered our Plzen Shopping and Entertainment Center to Klepierre, at 100% occupancy let out and
'/>"/>

SOURCE Elbit Imaging Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
2. Elbit Medical Imaging Ltd. Announces Adjournment of its Annual General Meeting
3. Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing
4. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
5. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
6. Elbit Imaging Ltd. Announces First Quarter Results for 2008
7. Brain imaging reveals breakdown of normal emotional processing
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. Fry Construction Selected for High-Profile Medical Imaging Project
10. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
11. Imaging Software Helps Track, Treat Injured Brains

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...begin to form between brain cells almost immediate...dy published this week in Nature . Led by researc...the study involved detailed observations of the re...ng motor learning. , The researchers studied mic...get a seed. They observed rapid growth of structur...
(Date:11/29/2009)...eatment equals a $41,000 pay raise, researchers sa... -- Psychological therapy may be much more effecti...winning a lottery prize, suggests an English study...eople who provided information about their mental ...s from a $1,329 course of therapy was so significa...
(Date:11/29/2009)...l healthcare,s uncertain future and rising costs o...e. Affordable Acupuncture Scottsdale answers the c...9, 2009 -- Affordable Acupuncture, LLC opened in S... met with enthusiasm and gratitude. Its increasing... two things, need and cost. "As far as I&rsq...
(Date:11/28/2009)... consider change after 30-minute psychosocial inte...7 (HealthDay News) -- A program that gets persiste...their dangerous behavior may lead to significant a..., The new study included 184 men and women with ...o were randomly assigned to one of two interventio...
(Date:11/27/2009)... GSI Group Inc. (Pink Sh...on technology products and semiconductor systems, ...any,s shareholders has been scheduled for Friday, ...ing will be announced in due course. As previousl...tice from Stephen Bershad, a holder of greater tha...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2
.... 9 Global multiservice public relations,agency W... panel discussion,titled "Healthcare Communication...Highly Regulated Environment." The presentation wi...eg/events/healthcare-webcast.aspx . , Interest...
...., Feb. 9 VNUS(R) Medical,Technologies, Inc. (Nas...es for,the minimally invasive treatment of venous ...nt at the Roth 21st Annual OC Growth Stock Confere...fficer and Vice,President of Finance and Administr...
...irin Announce Support of National Women,s Heart He...ORRISTOWN, N.J., Feb. 9 Bayer HealthCare LLC, the... support of WomenHeart, the nation,s only educatio...An estimated 44 million American women live with o...
...mulation of clopidogrel, the active ingredient in ... PRUSSIA, Pa., Feb. 9 Prism Pharmaceuticals ann...study of PM103, a novel intravenous formulation of...College of Cardiology (ACC) on March 29-31, 2009. ...
...led as One of the Top Achievements in 50 Years of ...(R) Brand, the original Rh immune globulin product...ing Rh-negative women in the prevention of Hemolyt...rld,s first injectable treatment to prevent the di...
..., Feb. 9 Shopko announced today that it won,first...he Year design,competition for the design of its n...in, early last year. Shopko,s new store design wil...g retail design firm Chute Gerdeman Retail in,conj...
Other Medicine News:Health News:Healthcare Online Regulations to Be Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease 2Health News:Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease 3Health News:Prism Pharmaceuticals' Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology 2Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 2Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 3Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 4Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 5Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 6Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 7Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 8Health News:Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives 9Health News:New Shopko Store Design Takes Top Honors 2Health News:New Shopko Store Design Takes Top Honors 3
(Date:11/27/2009)..., SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall/ ...ems, Inc. (NYSE: VAR ), a premier supplier of X-...will exhibit its full range of detectors at the RS...9 - December 3, 2009. Varian will also be exhibit...as well as specialized cancer treatment technologi...
(Date:11/26/2009)..., JOHANNESBURG, South Africa, Nov. 26 /PRNewswir...ompany of the Year Award in the Generic Pharmaceut...ica Limited. ,, (Logo: http://www.newscom.com/...ny of the Year Award, the following criteria were ...st key competitors: growth strategy and implementa...
(Date:11/25/2009)..., LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCall/...g provider of advanced diagnostic and specialty ...ay agreements with Roche Diagnostics Corporation f... consumables for the veterinary market. ,, (...22/HESKALOGO ) ,, "Heska and Roche share the sa...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 1Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 2Women with endometriosis need special care during pregnancy to avoid risk of premature birth 9079 1Women with endometriosis need special care during pregnancy to avoid risk of premature birth 9079 2New PICC Mimics Nature 50488 1New PICC Mimics Nature 50488 2
...quarter 2008 -, CAMBRIDGE, Mass., Sept. 18 Mille... announced that the interim,analysis results of th...,patients with newly diagnosed multiple myeloma sh...ednisone (VMP) demonstrated a highly statistically... including time-to-disease,progression, complete r...
...ries (NYSE: FRX ) announced today that single dos...onchodilatory response in 17 patients,with COPD ac...today at the,European Respiratory Society (ERS) An....newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ) ... values - important,measures of lung function - we...
Other Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 2Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 3Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 4Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 5
Machat Corneal Spatula
Koch Phacoemulsification Spatula
Hirschman Iris Lens Spatula
Lane Lasik Spatula
Medicine Products: